# Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension

> **NCT01850160** · PHASE3 · COMPLETED · sponsor: **Farma de Colombia SA** · enrollment: 124 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** GROUP A: Valsartan plus Chlorthalidone
- **DRUG:** GROUP B: Valsartan
- **DRUG:** GROUP C: Chlorthalidone

## Key facts

- **NCT ID:** NCT01850160
- **Lead sponsor:** Farma de Colombia SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-03
- **Final completion:** 2015-05
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2016-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01850160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01850160, "Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01850160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*